Prominent small bowel Ga-67 uptake associated with Yersinial and tuberculous enterocolitis

M. Brophey, L. Lamki, B. Barron, S. Shah

Research output: Contribution to journalArticle

Abstract

The nuclear medicine evaluation of the immunocompromised patient with fever of unknown origin may include the use of either labeled leukocytes or Ga-67 citrate, or both, in the search for an infectious focus. In recent years, labeled leukocytes (In-111 or Tc-99m) seem to have been employed preferentially by some. This is especially the case when the abdomen is a suspected site of involvement because of the normal colonic excretion of gallium that may complicate the interpretation of this study. The authors present the case of an immunocompromised patient with the interesting scintigraphic pattern of diffuse large and small bowel uptake of gallium secondary to biopsy proven Yersinia and tuberculous enterocolitis. A review of the recent literature reveals only one other similar case in which Yersinial disease was detected by Ga-67 scintigraphy. The present case illustrates that gallium's avidity for the atypical, less pyogenic, opportunistic infections common in immunocompromised patients justifies its continued use in such settings and, specifically, whenever tuberculosis is suspected.

Original languageEnglish
Pages (from-to)107-110
Number of pages4
JournalClinical Nuclear Medicine
Volume20
Issue number2
DOIs
Publication statusPublished - 1995

Fingerprint

Enterocolitis
Gallium
Immunocompromised Host
Leukocytes
Fever of Unknown Origin
Yersinia
Nuclear Medicine
Opportunistic Infections
Radionuclide Imaging
Abdomen
Tuberculosis
Biopsy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Prominent small bowel Ga-67 uptake associated with Yersinial and tuberculous enterocolitis. / Brophey, M.; Lamki, L.; Barron, B.; Shah, S.

In: Clinical Nuclear Medicine, Vol. 20, No. 2, 1995, p. 107-110.

Research output: Contribution to journalArticle

@article{cce42933ee594eb9828e45f3bd514b8d,
title = "Prominent small bowel Ga-67 uptake associated with Yersinial and tuberculous enterocolitis",
abstract = "The nuclear medicine evaluation of the immunocompromised patient with fever of unknown origin may include the use of either labeled leukocytes or Ga-67 citrate, or both, in the search for an infectious focus. In recent years, labeled leukocytes (In-111 or Tc-99m) seem to have been employed preferentially by some. This is especially the case when the abdomen is a suspected site of involvement because of the normal colonic excretion of gallium that may complicate the interpretation of this study. The authors present the case of an immunocompromised patient with the interesting scintigraphic pattern of diffuse large and small bowel uptake of gallium secondary to biopsy proven Yersinia and tuberculous enterocolitis. A review of the recent literature reveals only one other similar case in which Yersinial disease was detected by Ga-67 scintigraphy. The present case illustrates that gallium's avidity for the atypical, less pyogenic, opportunistic infections common in immunocompromised patients justifies its continued use in such settings and, specifically, whenever tuberculosis is suspected.",
author = "M. Brophey and L. Lamki and B. Barron and S. Shah",
year = "1995",
doi = "10.1097/00003072-199502000-00002",
language = "English",
volume = "20",
pages = "107--110",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Prominent small bowel Ga-67 uptake associated with Yersinial and tuberculous enterocolitis

AU - Brophey, M.

AU - Lamki, L.

AU - Barron, B.

AU - Shah, S.

PY - 1995

Y1 - 1995

N2 - The nuclear medicine evaluation of the immunocompromised patient with fever of unknown origin may include the use of either labeled leukocytes or Ga-67 citrate, or both, in the search for an infectious focus. In recent years, labeled leukocytes (In-111 or Tc-99m) seem to have been employed preferentially by some. This is especially the case when the abdomen is a suspected site of involvement because of the normal colonic excretion of gallium that may complicate the interpretation of this study. The authors present the case of an immunocompromised patient with the interesting scintigraphic pattern of diffuse large and small bowel uptake of gallium secondary to biopsy proven Yersinia and tuberculous enterocolitis. A review of the recent literature reveals only one other similar case in which Yersinial disease was detected by Ga-67 scintigraphy. The present case illustrates that gallium's avidity for the atypical, less pyogenic, opportunistic infections common in immunocompromised patients justifies its continued use in such settings and, specifically, whenever tuberculosis is suspected.

AB - The nuclear medicine evaluation of the immunocompromised patient with fever of unknown origin may include the use of either labeled leukocytes or Ga-67 citrate, or both, in the search for an infectious focus. In recent years, labeled leukocytes (In-111 or Tc-99m) seem to have been employed preferentially by some. This is especially the case when the abdomen is a suspected site of involvement because of the normal colonic excretion of gallium that may complicate the interpretation of this study. The authors present the case of an immunocompromised patient with the interesting scintigraphic pattern of diffuse large and small bowel uptake of gallium secondary to biopsy proven Yersinia and tuberculous enterocolitis. A review of the recent literature reveals only one other similar case in which Yersinial disease was detected by Ga-67 scintigraphy. The present case illustrates that gallium's avidity for the atypical, less pyogenic, opportunistic infections common in immunocompromised patients justifies its continued use in such settings and, specifically, whenever tuberculosis is suspected.

UR - http://www.scopus.com/inward/record.url?scp=0028896353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028896353&partnerID=8YFLogxK

U2 - 10.1097/00003072-199502000-00002

DO - 10.1097/00003072-199502000-00002

M3 - Article

VL - 20

SP - 107

EP - 110

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 2

ER -